MYAM
BSX icon

Meiji Yasuda Asset Management’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.78M Sell
72,408
-20,242
-22% -$2.17M 0.39% 69
2025
Q1
$9.35M Sell
92,650
-3,905
-4% -$394K 0.38% 67
2024
Q4
$8.62M Buy
96,555
+16,184
+20% +$1.45M 0.33% 78
2024
Q3
$6.74M Buy
80,371
+48,225
+150% +$4.04M 0.26% 101
2024
Q2
$2.48M Buy
32,146
+6,120
+24% +$471K 0.1% 195
2024
Q1
$1.78M Buy
26,026
+8,315
+47% +$569K 0.08% 235
2023
Q4
$1.02M Sell
17,711
-445
-2% -$25.7K 0.05% 319
2023
Q3
$959K Buy
18,156
+3,100
+21% +$164K 0.04% 326
2023
Q2
$814K Buy
15,056
+695
+5% +$37.6K 0.04% 317
2023
Q1
$718K Sell
14,361
-30
-0.2% -$1.5K 0.04% 336
2022
Q4
$666 Sell
14,391
-1,618
-10% -$75 0.03% 382
2022
Q3
$620K Sell
16,009
-2,460
-13% -$95.3K 0.04% 382
2022
Q2
$688K Buy
18,469
+1,590
+9% +$59.2K 0.04% 387
2022
Q1
$748K Sell
16,879
-1,645
-9% -$72.9K 0.04% 378
2021
Q4
$787K Buy
18,524
+1,748
+10% +$74.3K 0.05% 307
2021
Q3
$728K Sell
16,776
-810
-5% -$35.2K 0.05% 306
2021
Q2
$752K Buy
17,586
+1,160
+7% +$49.6K 0.04% 307
2021
Q1
$635K Buy
16,426
+6,645
+68% +$257K 0.05% 305
2020
Q4
$352K Sell
9,781
-540
-5% -$19.4K 0.03% 312
2020
Q3
$394K Sell
10,321
-10,770
-51% -$411K 0.04% 275
2020
Q2
$741K Buy
21,091
+10,350
+96% +$364K 0.07% 244
2020
Q1
$350K Sell
10,741
-13,380
-55% -$436K 0.07% 213
2019
Q4
$1.09M Sell
24,121
-8,920
-27% -$403K 0.09% 234
2019
Q3
$1.34M Sell
33,041
-410
-1% -$16.7K 0.11% 204
2019
Q2
$1.44M Sell
33,451
-16,310
-33% -$701K 0.12% 191
2019
Q1
$1.91M Sell
49,761
-5,090
-9% -$195K 0.16% 154
2018
Q4
$1.94M Sell
54,851
-860
-2% -$30.4K 0.18% 148
2018
Q3
$2.15M Buy
55,711
+1,320
+2% +$50.8K 0.17% 151
2018
Q2
$1.78M Sell
54,391
-1,180
-2% -$38.6K 0.16% 154
2018
Q1
$1.52M Buy
55,571
+3,360
+6% +$91.8K 0.14% 176
2017
Q4
$1.29M Hold
52,211
0.12% 207
2017
Q3
$1.52M Hold
52,211
0.15% 174
2017
Q2
$1.45M Sell
52,211
-9,800
-16% -$272K 0.15% 177
2017
Q1
$1.54M Buy
62,011
+10,730
+21% +$267K 0.16% 155
2016
Q4
$1.11M Buy
51,281
+33,770
+193% +$730K 0.12% 197
2016
Q3
$417K Buy
17,511
+4,720
+37% +$112K 0.05% 346
2016
Q2
$299K Buy
+12,791
New +$299K 0.04% 367